Graham Svoronos

(Ms. Dawn Svoronos)

Currently holds positions in PTC Therapeutics Inc, Xenon Pharmaceuticals Inc and Global Blood Therapeutics Inc

Positions

Position Company Period
Independent Director PTC Therapeutics Inc June 13, 2016 -
Independent Director Xenon Pharmaceuticals Inc Sept. 27, 2016 -
Independent Director Global Blood Therapeutics Inc Dec. 19, 2018 -
Director Endocyte Inc None -
Independent Director Medivation Inc Dec. 1, 2014 - Sept. 28, 2016
Interim Chief Commercial Officer, Director Medivation Inc July 10, 2014 - Dec. 1, 2014
Independent Director Medivation Inc April 1, 2013 - July 10, 2014
Graham Svoronos's trades of Xenon Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-24 2023-08-24
S Sale
25,000 -50.0%
38.70
USD 967,500 		25,000 -50.0% 38.70 USD 967,500
2023-05-11 2023-05-09
US ACELYRIN Inc (SLRN)
B Purchase
15,000 +inf%
18.00
USD 270,000 		15,000 +inf% 18.00 USD 270,000
2022-06-22 2022-06-21
PS Planned sale
1,908 -26.2%
27.24
USD 51,983 		1,908 -26.2% 27.24 USD 51,983
2022-06-10 2022-06-09
S Sale
738 -2.5%
27.20
USD 20,074 		738 -2.5% 27.20 USD 20,074
2022-05-18 2022-05-16
B Purchase
30,000 +150.0%
0.85
USD 25,578 		30,000 +150.0% 0.85 USD 25,578
2022-01-11 2022-01-07
S Sale
510 -1.9%
38.53
USD 19,648 		510 -1.9% 38.53 USD 19,648
2021-06-21 2021-06-18
PS Planned sale
1,609 -30.4%
36.54
USD 58,793 		1,609 -30.4% 36.54 USD 58,793
2021-06-11 2021-06-09
S Sale
365 -1.3%
41.89
USD 15,288 		365 -1.3% 41.89 USD 15,288
2021-04-01 2021-03-31
B Purchase
20,000 +inf%
10.02
USD 200,338 		20,000 +inf% 10.02 USD 200,338
2021-02-02 2021-02-01
S Sale
506 -1.8%
56.96
USD 28,820 		506 -1.8% 56.96 USD 28,820
2020-06-19 2020-06-19
PS Planned sale
881 -28.1%
64.42
USD 56,750 		881 -28.1% 64.42 USD 56,750
2020-06-19 2020-06-19
PS Planned sale
1,663 -34.6%
63.69
USD 105,913 		1,663 -34.6% 63.69 USD 105,913
2020-06-12 2020-06-11
S Sale
364 -1.4%
48.36
USD 17,603 		364 -1.4% 48.36 USD 17,603
// ... existing code ... // ... rest of the file ...